Transforming growth factor-β1 promotes the morphological and functional differentiation of the myofibroblast

Experimental Cell Research

Volumn 257, Issue 1, 2000, Pages 180-189

  Vaughan, Melville B ^a   Howard, Eric W ^a   Tomasek, James J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Collagen lattice; Fibronectin; Myofibroblast; Transforming growth factor 1; Wound healing; smooth muscle actin

Indexed keywords

ALPHA ACTIN; COLLAGEN; FIBRONECTIN; TRANSFORMING GROWTH FACTOR BETA1; VINCULIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MYOFIBROBLAST; PRIORITY JOURNAL;

EID: 0034713224     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4869     Document Type: Article

References (49)

1. Tomasek J. J., Vaughan M. B., Haaksma C. J. Cellular structure and biology of Dupuytren's disease. Hand Clin. 15:1999;21-34.
2. Gabbiani G., Majno G. Am. J. Pathol. 66:1972;131-146.
3. Darby I., Skalli O., Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab. Invest. 63:1990;21-29.
4. Tomasek J. J., Haaksma C. J. Fibronectin filaments and actin microfilaments are organized into a fibronexus in Dupuytren's diseased tissue. Anat. Rec. 230:1991;175-182.
5. Desmouliere A., Gabbiani G. Modulation of fibroblastic cytoskeletal features during pathological situations: The role of extracellular matrix and cytokines. Cell Motil. Cytoskeleton. 29:1994;195-203.
6. Singer I. I. The fibronexus: a transmembrane association of fibronectin-containing fibers and bundles of 5 nm microfilaments in hamster and human fibroblasts. Cell. 16:1979;675-685.
7. Singer I. I., Kawka D. W., Kazazis D. M., Clark R. A. In vivo. 98:1984;2091-2106.
8. Welch M. P., Odland G. F., Clark R. A. Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J. Cell Biol. 110:1990;133-145.
9. Schurch W., Skalli O., Gabbiani G. Cellular biology. McFarlane R. M., McGrouther D. A., Flint M. H. Dupuytren's Disease. 1990;31-47 Churchill Livingston, London.
10. Desmouliere A., Geinoz A., Gabbiani F., Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122:1993;103-111.
11. Ronnov-Jessen L., Petersen O. W. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab. Invest. 68:1993;696-707.
12. DeNofrio D., Hoock T. C., Herman I. M. Functional sorting of actin isoforms in microvascular pericytes. J. Cell Biol. 109:1989;191-202.
13. Herman I. M. Actin isoforms. Curr. Opin. Cell Biol. 5:1993;48-55.
14. Ronnov-Jessen L., Petersen O. W. A function for filamentous alpha-smooth muscle actin: Retardation of motility in fibroblasts. J. Cell Biol. 134:1996;67-80.
15. Tomasek J. J., Rayan G. M. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts. J. Hand Surg. [Am.]. 20:1995;450-455.
16. Moulin V., Castilloux G., Auger F. A., Garrel D., O'Connor-McCourt M. D., Germain L. Modulated response to cytokines of human wound healing myofibroblasts compared to dermal fibroblasts. Exp. Cell Res. 238:1998;283-293.
17. Montesano R., Orci L. Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: Implications for wound healing. Proc. Natl. Acad. Sci. USA. 85:1988;4894-4897.
18. Finesmith T. H., Broadley K. N., Davidson J. M. Fibroblasts from wounds of different stages of repair vary in their ability to contract a collagen gel in response to growth factors. J. Cell. Physiol. 144:1990;99-107.
19. Tingstrom A., Heldin C. H., Rubin K. Regulation of fibroblast-mediated collagen gel contraction by platelet-derived growth factor, interleukin-1 alpha and transforming growth factor-beta 1. J. Cell Sci. 102:1992;315-322.
20. Piscatelli S. J., Michaels B. M., Gregory P., Jennings R. W., Longaker M. T., Harrison M. R., Siebert J. W. Fetal fibroblast contraction of collagen matrices in vitro: The effects of epidermal growth factor and transforming growth factor-beta. Ann. Plast. Surg. 33:1994;38-45.
21. Reed M. J., Vernon R. B., Abrass I. B., Sage E. H. TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors. J. Cell. Physiol. 158:1994;169-179.
22. Yokozeki M., Moriyama K., Shimokawa H., Kuroda T. Transforming growth factor-beta 1 modulates myofibroblastic phenotype of rat palatal fibroblasts in vitro. Exp. Cell Res. 231:1997;328-336.
23. Fukamizu H., Grinnell F. Spatial organization of extracellular matrix and fibroblast activity: Effects of serum, transforming growth factor beta, and fibronectin. Exp. Cell Res. 190:1990;276-282.
24. Kurosaka H., Kurosaka D., Kato K., Mashima Y., Tanaka Y. Transforming growth factor-beta 1 promotes contraction of collagen gel by bovine corneal fibroblasts through differentiation of myofibroblasts. Invest. Ophthalmol. Vis. Sci. 39:1998;699-704.
25. Tomasek J. J., Haaksma C. J., Eddy R. J., Vaughan M. B. Fibroblast contraction occurs on release of tension in attached collagen lattices: Dependency on an organized actin cytoskeleton and serum. Anat. Rec. 232:1992;359-368.
26. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J. Cell Biol. 124:1994;401-404.
27. Parizi M., Howard E. W., Tomasek J. J. Regulation of LPA-promoted myofibroblast contraction: Role of Rho, myosin light chain kinase and myosin light chain phosphatase. Exp. Cell Res. 254:2000;210-220.
28. Mochitate K., Pawelek P., Grinnell F. Stress relaxation of contracted collagen gels: Disruption of actin filament bundles, release of cell surface fibronectin, and down-regulation of DNA and protein synthesis. Exp. Cell Res. 193:1991;198-207.
29. Ignotz R., Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261:1986;4337-4345.
30. Woods A., Couchman J. R., Johansson S., Hook M. Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments. EMBO J. 5:1986;665-670.
31. Woods A., McCarthy J. B., Furcht L. T., Couchman J. R. A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol. Biol. Cell. 4:1993;605-613.
32. Serini G., Bochaton-Piallat M. L., Ropraz P., Geinoz A., Borsi L., Zardi L., Gabbiani G. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta 1. J. Cell Biol. 142:1998;873-881.
33. Rayan G. M., Parizi M., Tomasek J. J. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro. J. Hand Surg. [Am.]. 21:1996;1065-1070.
34. Ronnov-Jessen L., Petersen O. W., Koteliansky V. E., Bissell M. J. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J. Clin. Invest. 95:1995;859-873.
35. Pilcher B. K., Kim D. W., Carney D. H., Tomasek J. J. Thrombin stimulates fibroblast-mediated collagen lattice contraction by its proteolytically activated receptor. Exp. Cell Res. 211:1994;368-373.
36. Halliday N. L., Tomasek J. J. Mechanical properties of the extracellular matrix influence fibronectin fibril assembly in vitro. Exp. Cell Res. 217:1995;109-117.
37. Borsi L., Castellani P., Risso A. M., Leprini A., Zardi L. Transforming growth factor-beta regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Lett. 261:1990;175-178.
38. Carnemolla B., Balza E., Siri A., Zardi L., Nicotra M. R., Bigotti A., Natali P. G. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J. Cell Biol. 108:1989;1139-1148.
39. Grande J. P. Role of transforming growth factor-beta in tissue injury and repair. Proc. Soc. Exp. Biol. Med. 214:1997;27-40.
40. Balza E., Borsi L., Allemanni G., Zardi L. Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett. 228:1988;42-44.
41. Allen-Hoffmann B. L., Crankshaw C. L., Mosher D. F. Transforming growth factor beta increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibroblasts. Mol. Cell. Biol. 8:1988;4234-4242.
42. Heino J., Ignotz R. A., Hemler M. E., Crouse C., Massague J. Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. J. Biol. Chem. 5:1989;380-388.
43. Tada A., Kato H., Takenaga K., Hasegawa S. Transforming growth factor beta 1 increases the expressions of high molecular weight tropomyosin isoforms and vinculin and suppresses the transformed phenotypes in human lung carcinoma cells. Cancer Lett. 121:1997;31-31.
44. Grinnell F., Ho C. H., Lin Y. C., Skuta G. Differences in the regulation of fibroblast contraction of floating versus stressed collagen matrices. J. Biol. Chem. 274:1999;918-923.
45. Arora P. D., McCulloch C. A. Dependence of collagen remodelling on alpha-smooth muscle actin expression by fibroblasts. J. Cell. Physiol. 159:1994;161-175.
46. Kolodney M. S., Elson E. L. Correlation of myosin light chain phosphorylation with isometric contraction of fibroblasts. J. Biol. Chem. 268:1993;23850-23855.
47. Chrzanowska-Wodnicka M., Burridge K. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J. Cell Biol. 133:1996;1403-1415.
48. Arora P. D., Narani N., McCulloch C. A. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am. J. Pathol. 154:1999;871-882.
49. Postlethwaite A. E., Keski-Oja J., Moses H. L., Kang A. H. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J. Exp. Med. 165:1987;251-256.